These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 21484784)
1. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice. Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784 [TBL] [Abstract][Full Text] [Related]
2. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis. Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity. Mumtaz IM; Hoyer BF; Panne D; Moser K; Winter O; Cheng QY; Yoshida T; Burmester GR; Radbruch A; Manz RA; Hiepe F J Autoimmun; 2012 Sep; 39(3):180-8. PubMed ID: 22727274 [TBL] [Abstract][Full Text] [Related]
4. Soluble human CD83 ameliorates lupus in NZB/W F1 mice. Starke C; Steinkasserer A; Voll RE; Zinser E Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695 [TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007 [TBL] [Abstract][Full Text] [Related]
6. Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW)F1 mice. Lacotte S; Dumortier H; Décossas M; Briand JP; Muller S J Immunol; 2010 Apr; 184(7):3937-45. PubMed ID: 20181885 [TBL] [Abstract][Full Text] [Related]
7. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice. Pau E; Chang NH; Loh C; Lajoie G; Wither JE Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847 [TBL] [Abstract][Full Text] [Related]
8. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887 [TBL] [Abstract][Full Text] [Related]
9. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice. Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377 [TBL] [Abstract][Full Text] [Related]
10. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974 [TBL] [Abstract][Full Text] [Related]
11. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Enghard P; Langnickel D; Riemekasten G Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368 [TBL] [Abstract][Full Text] [Related]
12. Inflamed kidneys of NZB / W mice are a major site for the homeostasis of plasma cells. Cassese G; Lindenau S; de Boer B; Arce S; Hauser A; Riemekasten G; Berek C; Hiepe F; Krenn V; Radbruch A; Manz RA Eur J Immunol; 2001 Sep; 31(9):2726-32. PubMed ID: 11536171 [TBL] [Abstract][Full Text] [Related]
13. Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors. Taddeo A; Khodadadi L; Voigt C; Mumtaz IM; Cheng Q; Moser K; Alexander T; Manz RA; Radbruch A; Hiepe F; Hoyer BF Arthritis Res Ther; 2015 Mar; 17(1):39. PubMed ID: 25889236 [TBL] [Abstract][Full Text] [Related]
14. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. Nakajima A; Hirose S; Yagita H; Okumura K J Immunol; 1997 Feb; 158(3):1466-72. PubMed ID: 9013993 [TBL] [Abstract][Full Text] [Related]
15. Local renal autoantibody production in lupus nephritis. Espeli M; Bökers S; Giannico G; Dickinson HA; Bardsley V; Fogo AB; Smith KG J Am Soc Nephrol; 2011 Feb; 22(2):296-305. PubMed ID: 21088295 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice. Khodadadi L; Cheng Q; Alexander T; Sercan-Alp Ö; Klotsche J; Radbruch A; Hiepe F; Hoyer BF; Taddeo A PLoS One; 2015; 10(8):e0135081. PubMed ID: 26252021 [TBL] [Abstract][Full Text] [Related]
17. Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche. Wang W; Rangel-Moreno J; Owen T; Barnard J; Nevarez S; Ichikawa HT; Anolik JH J Immunol; 2014 Apr; 192(7):3011-20. PubMed ID: 24574498 [TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice. Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287 [TBL] [Abstract][Full Text] [Related]
19. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis. Sainis K; Datta SK J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184 [TBL] [Abstract][Full Text] [Related]
20. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity. Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]